This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.

Burns Involving 60–69 Percent of Body Surface신체표면의 60-69%를 침범한 화상 (체표면적 60–69% 화상)

Contents and key points
ItemDetails
A. Classification codesICD-10: T31.6 (Burns involving 60-69% of body surface) | Special Copayment Reduction: V247 (Special Copayment Reduction for severe burns: 5% copayment for 1 year from the registration date)
B. Synonyms60-69% TBSA burn, very extensive burn, lethal burn 60-69% TBSA, burn of 2/3 of body surface
C. Adult onsetAbout 2/3 of the skin of the whole body is damaged, so autologous donor sites are severely lacking, the risk of multiple organ failure is very high, and long-term treatment at a specialized burn center is essential.
1. HistorySurvival with TBSA of 60% or more is an achievement of modern medicine; survival became possible with the triple strategy of CEA, allograft, and artificial skin
2. CausesLarge building fires, explosions, industrial accidents; situations where escape is impossible are the only context of occurrence
3. GeneticsSurvival of extreme systemic responses and genetic diversity; cytokine, coagulation, and renal function genes; sepsis susceptibility genes
4. General epidemiology1–3% of all burn admissions; mortality of 35–55% in young adults; mortality rises even more sharply above 60% TBSA
5. PathophysiologyExtreme burn shock; donor sites limited to 30–40%; recurrent sepsis; a cascade of multiple organ failure is the main pathway to death
6. SymptomsSevere shock and respiratory failure; decreased consciousness; symptoms of multiple organ failure; extreme metabolic expenditure
7. SignsRevised Baux 95–115; severe vital sign abnormalities; DIC, AKI, and ARDS commonly accompany
8. ScreeningImmediate TBSA, Baux, and SOFA; bronchoscopy; abdominal and compartment pressures; systemic culture surveillance
9. DiagnosisFull ICU monitoring; whole-body burn map; staged surgical plan; includes palliative care discussion
10. TreatmentMassive fluid volumes; use of allograft, CEA, and artificial skin together; intensive ICU care; aggressive nutrition and infection control
11. PrognosisSurvival at specialized centers 45–60%; mortality rises steeply with TBSA; long-term rehabilitation of 2–4 years after survival; quality of life is a major challenge
12. PreventionFire-fighting infrastructure and fire drills; chemical safety management; burn transfer networks; advance planning for palliative care
13. ReferencesWolf SE et al. Mortality determinants in massive pediatric burns … and 9 other papers

1. History

Survivors of burns of 60% TBSA or more began to appear only after the latter half of the 20th century. Until the 1960s, nearly 100% of patients with burns of 60% TBSA or more died, and burns of this magnitude were regarded as virtually incurable injuries. In the 1960s–70s, as experience with intensive care at specialized burn centers accumulated and fluid resuscitation and early surgical strategies developed, cases of survival began to be reported sporadically. However, the shortage of donor sites was a fundamental barrier to treatment in burns of 60% TBSA or more.

The development of CEA by Burke and Green in 1979 provided a decisive breakthrough in solving this problem. With this technique, sheets of skin large enough to cover the entire body could be cultured from a postage-stamp-sized piece of normal skin, theoretically making survival possible even in burns of 100% TBSA. In 1985, the Galveston burn center reported the first case of successful survival using CEA in a burn involving 97% TBSA, which had a great impact on the burn medicine community worldwide. With subsequent expansion of allograft skin banks, development of artificial dermis (Integra), immunomodulatory therapy, and precision nutritional support, survival for burns of 60–69% TBSA at specialized burn centers has now reached 45–60%. Specialized burn centers in Korea are also reporting cases of survival in patients with burns of 60% TBSA or more.


2. Causes

Very extensive burns reaching 60–69% TBSA can hardly occur in simple everyday accidents and occur in highly exceptional situations. In large building fires where escape is completely blocked, for example fires in nursing homes, psychiatric hospitals, and high-rise apartments, vulnerable patients unable to escape are the highest-risk group. Major explosions occur at chemical plants, gas storage facilities, coal mines, and military facilities and cause instantaneous, extensive flame exposure. Historically notable accidents (the 1979 Iri Station explosion in Korea, the 2003 Daegu subway fire, etc.) produced patients with burns of 60% TBSA or more.

Chemical causes include large-scale leakage and ignition of highly flammable chemicals and whole-body exposure to corrosive chemicals; in particular, when chemicals are absorbed through clothing and continue to act, the burn area can expand further. An electrical explosion (arc flash) reaches instantaneous temperatures of several thousand degrees and can cause extensive flame burns in electrical workers. Risk factors include reduced ability to escape (disability, old age, decreased consciousness), nighttime fires (during sleep), absence of a fire alarm system, and failure of initial fire suppression.


3. Genetics

Genetic factors that contribute to survival under the extreme physiological stress of burns of 60–69% TBSA act through multiple pathways. In this TBSA range, marked individual differences in survival appear even among patients receiving the same treatment, and studies suggest this is due to genetic diversity. Polymorphisms in TLR signaling pathway genes (TLR2, TLR4, MyD88) determine the strength of the innate immune response, and both excessively strong innate immune activation (cytokine storm) and an excessively weak response (immunoparalysis) are associated with a poor prognosis. There are research findings that patients with a TLR4 loss-of-function mutation (Asp299Gly) have an increased risk of gram-negative sepsis.

Polymorphisms in coagulation factor genes affect the risk of DIC. DIC is a common complication in burns of 60% TBSA or more, with bleeding due to coagulation factor deficiency and ischemia due to microthrombus formation progressing simultaneously. Patients with the Factor V Leiden variant or the Prothrombin 20210A variant have a higher tendency toward thrombus formation, which can worsen microcirculatory dysfunction. Polymorphisms in genes related to mitochondrial function also affect the capacity for cellular energy production under extreme metabolic stress and contribute to the likelihood of survival. There is currently no clinically available genetic test panel, but whole-genome analysis is being performed for research purposes at some centers treating extremely severe burns.


4. General epidemiology

Burns of 60–69% TBSA are a very rare severe injury, accounting for about 1–3% of all burn admissions. In this TBSA range, a clear pattern emerges in which mortality rises by an additional 15–20% for every 10% increase in TBSA, confirming that TBSA is the strongest predictor of death in burns. In young adults aged 20–40 treated at specialized burn centers, mortality for burns of 60–69% TBSA is about 35–55%, rising sharply to 70–90% in those aged 60 and older. Concomitant inhalation burns increase mortality by a further 20–30%.

By the Revised Baux Score, a 40-year-old patient with 65% TBSA and no inhalation burn scores 105, with an expected mortality of about 40–50%; with a concomitant inhalation burn, the score is 122 and the expected mortality exceeds 60–70%. The average length of hospital stay is 4–6 months, with an average of 8–15 operations. Total hospitalization costs can reach several hundred million won, and with Korea's V247 Special Copayment Reduction, the patient's copayment is limited to 5%. According to quality-of-life follow-up studies of survivors, return to work is possible in 15–30%, and permanent changes in appearance and functional impairment occur in nearly all survivors.


5. Pathophysiology

In burns of 60–69% TBSA, all physiological systems are simultaneously exposed to extreme stress. Extreme burn shock can progress to lethal hypovolemia within minutes to hours after the burn; by the Parkland formula, a patient with 65% TBSA weighing 70 kg = 4 × 70 × 65 = 18,200 mL, a massive fluid volume required in the first 24 hours. Fluid administration at this level greatly increases the risk of abdominal compartment syndrome, pulmonary edema, and extremity compartment syndrome. An absolute shortage of donor sites is the greatest barrier to treatment; only 30–40% of the total skin remains as normal skin, and it is impossible to cover the entire burn wound with this area. A triple strategy of CEA culture (taking 3–4 weeks), allograft skin (temporary closure), and artificial dermis (dermal reconstruction) must be carried out over several months.

Recurrent sepsis is the most common cause of death in this TBSA range. While open wounds persist for months until wound closure is complete, bacterial and fungal infections recur, showing a pattern that begins with gram-positive bacteria (MRSA) and later shifts to multidrug-resistant gram-negative bacteria (MRSA, Pseudomonas aeruginosa, Acinetobacter, ESBL-producing Enterobacteriaceae). The systemic hypermetabolic response raises the basal metabolic rate to more than 200% of normal, and without adequate nutrition, severe muscle wasting and impaired immune function develop within a few weeks.


6. Symptoms

The initial symptoms of patients with burns of 60–69% TBSA reflect a life-threatening critical condition. Severe pain appears in some areas immediately after the burn, but when the proportion of deep injury is high, reduced sensation across the whole body may accompany it, so complaints of pain may be disproportionately small relative to the TBSA. Within tens of minutes after the burn, intense thirst, awareness of a rapid heartbeat, extreme anxiety and fear, and coldness of the extremities appear, which signal the onset of burn shock. Decreased consciousness appears as shock progresses and, without adequate resuscitation, progresses to loss of consciousness.

During treatment after admission, recurrent high fever (sepsis), sudden drops in blood pressure (septic shock), sharp decreases in urine output (AKI), jaundice (impaired liver function), and changes in consciousness (septic encephalopathy) appear periodically. During mechanical ventilation, it is difficult for patients to directly express the symptoms they experience, but on assessment after adjusting the depth of sedation, pain, anxiety, and delirium are commonly identified. In the later phase of treatment, severe muscle weakness, weight loss (possible loss of 25–35% of initial body weight), limited movement due to joint contractures, and scar itching become persistent problems.


7. Signs

Vital signs in burns of 60–69% TBSA show serious abnormalities requiring immediate initiation of treatment. Severe tachycardia of 140–160 beats/min or more, hypotension with systolic blood pressure of 70–80 mmHg, anuria or severe oliguria, and hypothermia with a rectal temperature of 35°C or lower or high fever of 39°C or higher may occur. Decreased pulse oximetry readings and tachypnea suggest ARDS or inhalation burn. The Revised Baux Score is mostly in the 95–115+ range and, with a concomitant inhalation burn, exceeds 110–130, indicating a very high risk of death. DIC findings include spontaneous bleeding (injection sites, mucosal bleeding), thrombocytopenia, and extreme prolongation of PT/aPTT. An abdominal pressure of 20 mmHg or higher indicates abdominal compartment syndrome, and laparotomy should be considered.


8. Screening

In burns of 60–69% TBSA, screening tests are performed simultaneously with the start of resuscitation, without delay. Tests to perform immediately: arterial blood gas analysis (including COHb and lactate), complete blood count, coagulation, electrolytes, renal function, liver function, blood glucose, electrocardiogram, chest X-ray, and bladder pressure measurement. TBSA estimation (Lund-Browder) and immediate calculation of the Revised Baux Score determine prognosis and treatment intensity. The SOFA score is calculated to quantify multiorgan function. Assessment for inhalation burn is performed immediately; if an inhalation burn is suspected, the airway is directly examined by bronchoscopy and early endotracheal intubation is decided. At this TBSA level, it is ethically important to explain the prognosis based on the Revised Baux Score to the patient and family and to discuss advance wishes regarding life-sustaining treatment early.


9. Diagnosis

Patients with burns of 60–69% TBSA are admitted to the burn intensive care unit (Burn ICU) immediately on admission, and an arterial line, central venous catheter, indwelling urinary catheter, and nasogastric tube (for feeding) are inserted. A whole-body burn map is drawn on a Lund-Browder chart, and the proportion of deep burns is estimated to calculate the area requiring grafting relative to the donor sites. Based on this, a staged surgical plan is established, and allograft skin and artificial dermis are used as temporary coverings in the interval between operations (about 1–2 weeks). For CEA, a biopsy is taken from the patient's normal skin early in the admission and culture starts immediately; it is ready for use 3–4 weeks later. Bacterial culture surveillance is performed 2–3 times a week, and antibiotics are adjusted according to culture results. When sepsis develops, it is diagnosed immediately by the Sepsis-3 criteria and the 1-hour bundle (blood cultures → antibiotic administration → fluid resuscitation → lactate measurement) is carried out.


10. Treatment

In a patient with 65% TBSA weighing 70 kg, the Parkland formula fluid volume = 18,200 mL is given over the first 24 hours, with hourly monitoring of urine output (target 0.5–1 mL/kg/hr) and bladder pressure (reduce the infusion rate or consider laparotomy at 20 mmHg or higher). To prevent "fluid creep" (excessive fluid) during resuscitation, an upper limit based on target body weight is set within 24 hours, and if exceeded, a diuretic (furosemide) or plasma colloid (albumin) is added to correct colloid osmotic pressure. Wound management begins with early excision (starting within 48–72 hours after the burn if possible) and temporary allograft coverage, followed by staged wound closure using CEA and artificial dermis. Autologous donor sites are expanded as much as possible with mesh grafts (1:4–1:6 expansion), and harvesting is repeated 3–4 weeks later once the donor sites have re-epithelialized (donor site cycling). Beta-blockers (propranolol), intensive insulin therapy (blood glucose 140–180 mg/dL), and high-protein (2.5 g/kg/day) nutritional support are given concurrently.


11. Prognosis

The overall survival of patients with burns of 60–69% TBSA treated at specialized burn centers is 45–60%, a figure obtained under optimal treatment conditions. The tendency for mortality to rise by an additional 15–20% for every 10% increase in TBSA persists in this TBSA range, confirming a strong correlation between TBSA and mortality. About 55–65% of deaths are due to sepsis and septic shock, ARDS and multiple organ failure account for 20–25%, and burn shock and airway problems for 10–15%. The median time to onset of sepsis is 10–14 days after the burn. The average length of hospital stay for survivors is 4–6 months, requiring 8–15 operations and 3–5 years of outpatient rehabilitation. PTSD develops in about 40–60% of long-term survivors, and return to work is possible in 15–25%.


12. Prevention

The key to preventing very extensive burns of 60% TBSA or more is building national-level fire safety infrastructure. Mandatory installation of automatic sprinkler systems in all multi-use facilities (apartments, nursing homes, factories, commercial facilities) is the most effective structural means of prevention. Fire alarm systems alert occupants immediately when a fire breaks out so they can evacuate, preventing fatal delays especially in nighttime fires. Strengthening fire safety infrastructure for vulnerable groups (nursing homes, psychiatric hospitals, facilities for people with disabilities) and mandating regular evacuation drills are important. Explosion prevention systems, regular safety inspections, and compliance with hazardous materials regulations at workplaces handling chemicals also contribute to preventing major burns at industrial sites. Strengthening the national burn transfer network and helicopter transport system allows patients of this severity to reach specialized burn centers quickly, increasing survival.


13. References

  1. Wolf SE, Rose JK, Desai MH, Mileski JP, Barrow RE, Herndon DN. Mortality determinants in massive pediatric burns. Ann Surg. 1997;225(5):554-569. DOI: 10.1097/00000658-199705000-00012. PMID: 9193182.

  2. Osler T, Glance LG, Hosmer DW. Simplified estimates of the probability of death after burn injuries. J Trauma. 2010;68(3):690-697. DOI: 10.1097/TA.0b013e3181c453b3. PMID: 20220427.

  3. Jeschke MG, van Baar ME, Choudhry MA, et al. Burn injury. Nat Rev Dis Primers. 2020;6(1):11. DOI: 10.1038/s41572-020-0145-5. PMID: 32054846.

  4. Greenhalgh DG. Sepsis in the burn patient: a different problem. Burns Trauma. 2017;5:23. DOI: 10.1186/s41038-017-0089-9. PMID: 28748182.

  5. Alvarado R, Chung KK, Cancio LC, Wolf SE. Burn resuscitation. Burns. 2009;35(1):4-14. DOI: 10.1016/j.burns.2008.03.008. PMID: 18675523.

  6. Rousseau AF, Losser MR, Ichai C, Berger MM. ESPEN endorsed recommendations: nutritional therapy in major burns. Clin Nutr. 2013;32(4):497-502. DOI: 10.1016/j.clnu.2013.02.012. PMID: 23582468.

  7. Sheridan RL, Tompkins RG. What's new in burns and metabolism. J Am Coll Surg. 2004;198(2):243-263. DOI: 10.1016/j.jamcollsurg.2003.09.027. PMID: 14759783.

  8. Herndon DN, Barrow RE, Rutan RL, et al. Effect of inhalation injury on mortality of burn patients. J Trauma. 1988;28(3):290-294. DOI: 10.1097/00005373-198803000-00003. PMID: 3351975.

  9. Brusselaers N, Monstrey S, Vogelaers D, Hoste E, Blot S. Severe burn injury in Europe. Crit Care. 2010;14(5):R188. DOI: 10.1186/cc9300. PMID: 20958964.

  10. Orgill DP. Excision and skin grafting of thermal burns. N Engl J Med. 2009;360(9):893-901. DOI: 10.1056/NEJMct0804451. PMID: 19246361.